Intro

This chapter explores Pneumocystis jirovecii pneumonia, focusing on its causes, risk factors, and demographic shifts in incidence. It highlights the vulnerability of immunocompromised individuals, particularly those with low CD4 counts and those undergoing high-dose glucocorticoid treatments.